Research Square (Research Square),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Oct. 26, 2022
Abstract
Neuroinflammation
is
an
important
hallmark
in
amyotrophic
lateral
sclerosis
(ALS).
Experimental
evidence
has
highlighted
a
role
of
microglia
the
modulation
motor
neuron
degeneration.
However,
exact
contribution
to
both
sporadic
and
genetic
forms
ALS
still
unclear.
We
generated
single
nuclei
profiles
spinal
cord
cortex
from
C9orf72
patients,
as
well
controls.
particularly
focused
on
transcriptomic
responses
astrocytes.
confirmed
that
highly
expressed
shows
diminished
expression
carriers
hexanucleotide
repeat
expansion
(HRE).
This
resulted
impaired
response
disease,
with
specific
deficits
phagocytic
lysosomal
transcriptional
pathways.
Astrocytes
also
displayed
dysregulated
remaining
homeostatic
state.
suggests
HRE
alters
coordinated
glial
response,
which
ultimately
would
increase
risk
for
developing
ALS.
Our
results
indicate
selective
microglial
loss-of-function,
likely
impairing
microglial-astrocyte
communication
preventing
global
response.
relevant
it
indicates
familial
may
present
different
cellular
substrate,
great
importance
patient
stratification
treatment.
Neuron,
Journal Year:
2023,
Volume and Issue:
111(3), P. 328 - 344.e7
Published: Feb. 1, 2023
The
mammalian
spinal
cord
functions
as
a
community
of
cell
types
for
sensory
processing,
autonomic
control,
and
movement.
While
animal
models
have
advanced
our
understanding
cellular
diversity,
characterizing
human
biology
directly
is
important
to
uncover
specialized
features
basic
function
pathology.
Here,
we
present
taxonomy
the
adult
using
single-nucleus
RNA
sequencing
with
spatial
transcriptomics
antibody
validation.
We
identified
29
glial
clusters
35
neuronal
clusters,
organized
principally
by
anatomical
location.
To
demonstrate
relevance
this
resource
disease,
analyzed
motoneurons,
which
degenerate
in
amyotrophic
lateral
sclerosis
(ALS)
other
diseases.
found
that
compared
neurons,
motoneurons
are
defined
genes
related
size,
cytoskeletal
structure,
ALS,
suggesting
molecular
repertoire
underlying
their
selective
vulnerability.
include
web
facilitate
further
investigations
into
biology.
Immunity,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 1, 2025
Amyotrophic
lateral
sclerosis
(ALS)
is
a
progressive
neurodegenerative
disease
characterized
by
motor
neuron
loss.
Microglia
and
astrocyte-driven
neuroinflammation
prominent
in
ALS,
but
the
cell
state
dynamics
pathways
driving
remain
unclear.
We
performed
single-nucleus
RNA
sequencing
of
ALS
spinal
cords
identified
altered
glial
states,
including
increased
expression
inflammatory
activation
markers.
Many
these
signals
converged
on
inflammation
death
regulator
receptor-interacting
protein
kinase
1
(RIPK1)
necroptotic
pathway.
In
superoxide
dismutase
(SOD1)G93A
mice,
blocking
RIPK1
activity
delayed
symptom
onset
impairment
modulated
responses.
used
human
induced
pluripotent
stem
(iPSC)-derived
neuron,
astrocyte,
microglia
tri-cultures
to
identify
potential
biomarkers
that
are
secreted
upon
vitro
inhibition
cerebrospinal
fluid
(CSF)
people
with
ALS.
These
data
reveal
ALS-enriched
populations
associated
suggest
deleterious
role
for
neuroinflammatory
signaling
pathogenesis.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: April 6, 2023
Astrocytes
are
a
highly
abundant
glial
cell
type
that
perform
critical
homeostatic
functions
in
the
central
nervous
system.
Like
neurons,
astrocytes
have
many
discrete
heterogenous
subtypes.
The
subtype
identity
and
are,
at
least
part,
associated
with
their
anatomical
location
can
be
restricted
to
strategically
important
domains.
Here,
we
report
forming
glia
limitans
superficialis,
outermost
border
of
brain
spinal
cord,
specialized
astrocyte
identified
by
single
marker:
Myocilin
(Myoc).
We
show
Myoc+
cover
entire
cord
surface,
exhibit
an
atypical
morphology,
evolutionarily
conserved
from
rodents
humans.
Identification
this
will
advance
our
understanding
CNS
homeostasis
potentially
targeted
for
therapeutic
intervention
combat
peripheral
inflammatory
effects
on
CNS.
Communications Biology,
Journal Year:
2025,
Volume and Issue:
8(1)
Published: March 2, 2025
Inflammation
is
a
hallmark
of
amyotrophic
lateral
sclerosis
(ALS),
particularly
in
cases
with
SOD1
mutations.
Using
integrative
transcriptomics,
we
analyzed
gene
expression
changes
mouse
models
throughout
progression,
human
induced-pluripotent
stem
cells
(hiPSCs),
and
post-mortem
spinal
cord
tissue
from
ALS
patients.
We
identified
conserved
upregulation
interferon
(IFN)
genes
IFN-stimulating
(ISGs)
both
ALS,
predominance
Type
I
IFNs
(IFN-α/β)
mice
II
(IFN-γ)
humans.
In
models,
observed
robust
sustained
ISGs,
including
ATF3,
beginning
at
disease
onset
stage
persisting
progression.
Single-cell
transcriptomics
further
pinpointed
vascular
endothelial
as
major
source
ISGs.
Furthermore,
found
that
the
STING-TBK1
axis
essential
for
induction
ISGs
its
deletion
impaired
their
expression.
Our
study
uncovers
signature
across
patients,
highlighting
potential
role
innate
immune
activation
pathogenesis.
These
findings
suggest
may
serve
biomarkers
therapeutic
targets
ALS.
Integrative
patients
reveals
type
driven
by
STING-mediated
activation.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 26, 2025
Amyotrophic
lateral
sclerosis
(ALS)
is
a
fatal
and
rapidly
evolving
neurodegenerative
disease
arising
from
the
loss
of
glutamatergic
corticospinal
neurons
(CSN)
cholinergic
motoneurons
(MN).
Here,
we
performed
comparative
cross-species
transcriptomics
CSN
using
published
snRNA-seq
data
motor
cortex
ALS
control
postmortem
tissues,
longitudinal
RNA-seq
on
purified
male
Sod1G86R
mice.
We
report
that
undergo
ER
stress
altered
mRNA
translation,
identify
transcription
factor
CREB3
its
regulatory
network
as
resilience
marker
ALS,
not
only
amongst
vulnerable
neuronal
populations,
but
across
all
populations
well
other
cell
types.
Using
genetic
epidemiologic
analyses
further
rare
variant
CREB3R119G
(rs11538707)
positive
modifier
in
ALS.
Through
gain
function,
decreases
risk
developing
progression
rate
patients.
Cross-species
unravels
markers
Genetics
epidemiology
protective
CREB3R119G.
PLoS ONE,
Journal Year:
2024,
Volume and Issue:
19(3), P. e0299567 - e0299567
Published: March 8, 2024
Amyotrophic
lateral
sclerosis
(ALS)
is
neurodegenerative
disease
characterized
by
a
progressive
loss
of
motor
neurons
resulting
in
paralysis
and
muscle
atrophy.
One
the
most
prospective
hypothesis
on
ALS
pathogenesis
suggests
that
excessive
inflammation
advanced
glycation
end-products
(AGEs)
accumulation
play
crucial
role
development
patients
SOD1
G93A
mice.
Hence,
we
may
speculate
RAGE,
receptor
for
its
proinflammatory
ligands
such
as:
HMGB1,
S100B
CML
contribute
to
pathogenesis.
The
aim
our
studies
was
decipher
RAGE
as
well
provide
insight
into
signaling
pathways
during
progression
RAGE-deficient
In
study,
observed
alternations
molecular
pattern
KO
mice
compared
Moreover,
amount
beta
actin
(ACTB)
Glial
fibrillary
acidic
protein
(GFAP)
elevated
when
with
deletion
RAGE.
These
data
contributes
understanding
implications
highlight
potential
targeted
therapeutic
interventions
at
early
stage
this
devastating
disease.
inhibition
cross-talk
between
abolish
neuroinflammation,
gliosis
neuron
damage
hypothesize
attenuated
interaction
improve
well-being
health
status
Therefore,
emphasize
pathway
be
target
diseases.
Ageing Research Reviews,
Journal Year:
2023,
Volume and Issue:
92, P. 102126 - 102126
Published: Nov. 15, 2023
Amyotrophic
lateral
sclerosis
(ALS)
is
a
neurodegenerative
disorder
and
the
most
common
motor
neuron
disease.
ALS
shows
substantial
clinical
molecular
heterogeneity.
In
vitro
in
vivo
models
coupled
with
multiomic
techniques
have
provided
important
contributions
to
unraveling
pathomechanisms
underlying
ALS.
To
date,
despite
promising
results
accumulating
knowledge,
an
effective
treatment
still
lacking.
Here,
we
provide
overview
of
literature
on
use
genomics,
epigenomics,
transcriptomics
microRNAs
deeply
investigate
mechanisms
developing
sustaining
We
report
relevant
genes
implicated
pathogenesis,
discussing
different
high-throughput
sequencing
role
epigenomic
modifications.
Furthermore,
present
transcriptomic
studies
recent
advances,
from
microarrays
bulk
single-cell
RNA
sequencing.
Finally,
discuss
as
potential
biomarkers
tools
for
intervention.
The
integration
data
multiple
omic
approaches
may
new
insights
into
pathogenic
pathways
by
shedding
light
diagnostic
prognostic
biomarkers,
helping
stratify
patients
clinically
subgroups,
revealing
novel
therapeutic
targets
supporting
development
therapies.
Scientific Reports,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: April 21, 2023
Abstract
The
role
of
glia
in
amyotrophic
lateral
sclerosis
(ALS)
is
undeniable.
Their
disease-related
activity
has
been
extensively
studied
the
spinal
cord,
but
only
partly
brain.
We
present
herein
a
comprehensive
study
cortex
SOD1(G93A)
mice—a
widely
used
model
ALS.
Using
single-cell
RNA
sequencing
(scRNA-seq)
and
immunohistochemistry,
we
inspected
astrocytes,
microglia,
oligodendrocytes,
four
stages
disease,
respecting
factor
sex.
report
minimal
changes
throughout
disease
progression
regardless
Pseudobulk
analyses
revealed
subtle
transcriptional
alterations
at
end-stage
microglia
which
were
supported
by
immunohistochemistry.
Therefore,
our
data
support
hypothesis
that
mouse
does
not
recapitulate
patients,
recommend
use
different
for
future
studies
cortical
ALS
pathology.